Universe Pharmaceuticals Stock (NASDAQ:UPC)


OwnershipChart

Previous Close

$2.05

52W Range

$1.78 - $64.80

50D Avg

$6.47

200D Avg

$30.21

Market Cap

$2.92M

Avg Vol (3M)

$219.71K

Beta

1.54

Div Yield

-

UPC Company Profile


Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CN

Employees

225

IPO Date

Mar 23, 2021

Website

UPC Performance


Peer Comparison


TickerCompany
QLIQilian International Holding Group Limited
TKNOAlpha Teknova, Inc.
PAHCPhibro Animal Health Corporation
RGCRegencell Bioscience Holdings Limited
SSICSilver Spike Investment Corp.
PROCProcaps Group S.A.
IMCCIM Cannabis Corp.
EGRXEagle Pharmaceuticals, Inc.